Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 4/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | CBS | P35520 | 1/20 | 0.47 |
| ▸ | LTA4H | P09960 | 1/20 | 0.45 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.44 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.44 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.44 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.44 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.42 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.42 |
| ▸ | OPRK1 | P41145 | 3/20 | 0.42 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | FUT7 | Q11130 | 1/20 | 0.39 |
| ▸ | TYR | P14679 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4641755 | 0.94 | PTGS2 (0.61) | PTGS2CYP3A4CBSLTA4HGRIN2D | |
| SCHEMBL16433077 | 0.92 | PTGS2 (0.62) | PTGS2CYP3A4CBSLTA4HOPRM1 | |
| SCHEMBL16431479 | 0.92 | PTGS2 (0.62) | PTGS2CYP3A4CBSLTA4HOPRM1 | |
| SCHEMBL14253525 | 0.86 | PTGS2 (0.50) | PTGS2CYP3A4CBSLTA4HOPRM1 | |
| SCHEMBL22528225 | 0.85 | PTGS2 (0.55) | PTGS2CYP3A4CBSLTA4HACHE | |
| SCHEMBL9123014 | 0.84 | GRIN2D (0.46) | PTGS2CYP3A4GRIN2DGRIN2AGRIN2B | |
| SCHEMBL25403702 | 0.82 | GRIN2D (0.56) | PTGS2CYP3A4GRIN2DGRIN2AGRIN2B | |
| SCHEMBL24195878 | 0.80 | PTGS2 (0.60) | PTGS2CYP3A4CBSLTA4H | |
| SCHEMBL27798205 | 0.79 | PTGS2 (0.47) | PTGS2CYP3A4GRIN2DGRIN2AGRIN2B | |
| SCHEMBL104946 | 0.78 | ESR1 (0.55) | PTGS2CYP3A4GRIN2DGRIN2AGRIN2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11129781-B2 | Agent for hair deforming treatment | KAO CORPORATION (JP) | 2021-09-28 | — | — | US | disclosed |
| US-11045402-B2 | Hair cosmetic composition | KAO CORPORATION (JP) | 2021-06-29 | — | — | US | disclosed |
| US-10959925-B2 | Hair cosmetic composition | KAO CORPORATION (JP) | 2021-03-30 | — | — | US | disclosed |
| EP-3228302-B1 | HAIR DEFORMATION TREATMENT AGENT | KAO CORP (JP) | 2020-09-02 | — | — | EP | disclosed |
| CN-106999382-B | Hair deforming agent | 花王株式会社 | 2020-07-10 | — | — | CN | disclosed |
| CN-106999380-B | Hair deforming agent | 花王株式会社 | 2020-05-05 | — | — | CN | disclosed |
| US-20190290564-A1 | HAIR COSMETIC COMPOSITION | KAO CORPORATION (JP) | 2019-09-26 | — | — | US | disclosed |
| US-20190254943-A1 | HAIR COSMETIC COMPOSITION | KAO CORPORATION (JP) | 2019-08-22 | — | — | US | disclosed |
| US-20190224093-A1 | HAIR COSMETIC COMPOSITION | KAO CORPORATION (JP) | 2019-07-25 | — | — | US | disclosed |
| US-20190125052-A1 | METHOD FOR TREATING HAIR | KAO CORPORATION (JP) | 2019-05-02 | — | — | US | disclosed |
| WO-2017207768-A1 | METHOD FOR TREATING HAIR | KAO CORPORATION (JP) | 2017-12-07 | — | — | WO | disclosed |
| EP-3228302-A1 | HAIR DEFORMATION TREATMENT AGENT | Kao Corporation (JP) | 2017-10-11 | — | — | EP | disclosed |
| EP-3228300-A1 | HAIR DEFORMATION TREATMENT AGENT | Kao Corporation (JP) | 2017-10-11 | — | — | EP | disclosed |
| EP-2479203-A1 | AROMATIC POLYESTER | Muroran Institute of Technology (JP) | 2012-07-25 | — | — | EP | disclosed |
| US-20120172570-A1 | AROMATIC POLYESTER | NITTA CORPORATION | 2012-07-05 | — | — | US | disclosed |
| US-8129493-B2 | Aromatic polyester | MURORAN INSTITUTE OF TECHNOLOGY (JP) | 2012-03-06 | — | — | US | disclosed |
| US-20110224343-A1 | MODIFIER FOR AROMATIC POLYESTER AND AROMATIC POLYESTER RESIN COMPOSITION COMPRISING THE SAME | MURORAN INSTITUTE OF TECHNOLOGY (JP) | 2011-09-15 | — | — | US | disclosed |
| US-20110092662-A1 | AROMATIC POLYESTER | NITTA CORPORATION (JP) | 2011-04-21 | — | — | US | disclosed |
| EP-0065720-B1 | PROCESS FOR PREPARING HYDROXYPHENYL AMINE DERIVATIVES | CASSELLA Aktiengesellschaft (DE) | 1985-01-09 | — | — | EP | disclosed |
| EP-0065720-A1 | Process for preparing hydroxyphenyl amine derivatives | CASSELLA Aktiengesellschaft (DE) | 1982-12-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110224343-A1 | MODIFIER FOR AROMATIC POLYESTER AND AROMATIC POLYESTER RESIN COMPOSITION COMPRISING THE SAME | F12, PHAX, WDR82 | PTGS2 2866/4885CYP3A4 2028/4885CBS 4580/4885 |
| US-11045402-B2 | Hair cosmetic composition | CUTA, GRHPR, POLR1C | PTGS2 1901/4885CYP3A4 1895/4885CBS 1214/4885 |
| US-10959925-B2 | Hair cosmetic composition | CUTA, POLR1C, GRHPR | PTGS2 2392/4885CYP3A4 1786/4885CBS 1104/4885 |
| US-20190254943-A1 | HAIR COSMETIC COMPOSITION | CUTA, POLR1C, GRHPR | PTGS2 2392/4885CYP3A4 1786/4885CBS 1104/4885 |
| US-20190125052-A1 | METHOD FOR TREATING HAIR | GRHPR, TYR, POLR1C | PTGS2 1194/4885CYP3A4 848/4885CBS 1559/4885 |
| US-20190224093-A1 | HAIR COSMETIC COMPOSITION | CUTA, GRHPR, POLR1C | PTGS2 1901/4885CYP3A4 1895/4885CBS 1214/4885 |
| US-11129781-B2 | Agent for hair deforming treatment | GRHPR, SLC26A4, COL1A1 | PTGS2 3041/4885CYP3A4 3291/4885CBS 2595/4885 |
| US-20190290564-A1 | HAIR COSMETIC COMPOSITION | GRHPR, POLR1C, TYR | PTGS2 2467/4885CYP3A4 1647/4885CBS 1377/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.